Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 16 JANUARY 2024

Corporate Transparency Act: Action Plan For Upcoming Reporting Requirements

Greenberg Glusker LLP
Greenberg Glusker LLP
Contributor
Greenberg Glusker LLP

Greenberg Glusker LLP

Overview Greenberg Glusker is a full-service law firm in Los Angeles, California with clients that...

View firm profile
Explore more from Greenberg Glusker LLP

Back in August, our firm released an alert on the Corporate Transparency Act (the "CTA"), summarizing the reporting obligations...

United StatesCorporate/Commercial Law
Greenberg Glusker Fields Claman & Machtinger
Greenberg Glusker Fields Claman & Machtinger
Robin Finch
Robin Finch
James Han
James Han
Stefanie J. Lipson
Stefanie J. Lipson
Schuyler M. Moore
Schuyler M. Moore
Joel Weinstein
Joel Weinstein
Laura A. Zwicker
Laura A. Zwicker
Author LinkedIn connections

Back in August, our firm released an alert on the Corporate Transparency Act (the "CTA"), summarizing the reporting obligations and the important deadlines for entities that will be considered "reporting companies" under the CTA. This article summarizes Greenberg Glusker's policies with respect to the CTA and actions that you can take now to prepare.

Reports and Deadlines

Commencing on January 1, 2024, most entities formed by a filing with a secretary of state's office (including, corporations, limited partnerships, limited liability companies, limited liability limited partnerships, and statutory trusts) must file a report (the "CTA Report") to the Financial Crimes Enforcement Network ("FinCEN"), reporting certain information about the entity and the persons who own and control it. The initial filing deadlines are as follows:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Healthcare Trends & Transactions Q2 2026

Healthcare M&A activity maintained steady momentum through Q2 2026, driven by physician practice consolidation, AI-enabled technology acquisitions, and strategic outpatient expansion. Private equity investment persisted despite intensifying regulatory scrutiny of MSO arrangements, while digital health buyers paid significant premiums for platforms demonstrating production-grade AI capabilities and proprietary data assets.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

CLIENT ALERT: 2026 Mid-Year Update On SEC And CFTC Enforcement

The SEC and CFTC have fundamentally shifted their enforcement approach in 2026, moving away from high-volume technical violations toward targeted actions addressing serious fraud and market manipulation. This mid-year update examines new leadership priorities, enhanced inter-agency coordination, revised cooperation policies, the elimination of "no-deny" settlement provisions, and a landmark Supreme Court ruling on disgorgement that collectively reshape the regulatory landscape for market participants.
United StatesCorporate/Commercial Law
Sher Tremonte
Sher Tremonte
Article

Sanofi And Regeneron Expand Immunology Collaboration In Deal Worth Up To $8 Billion

Sanofi and Regeneron Pharmaceuticals announce a major expansion of their immunology partnership, committing up to $8 billion to develop and commercialize four long-acting antibodies targeting key inflammatory pathways. The collaboration includes a $1 billion upfront payment and milestone-based payments, with both companies sharing development costs and future profits equally.
United StatesCorporate/Commercial Law
Goodwin Procter LLP
Goodwin Procter LLP
Article

FDA Proposes To Modify Self-Certification Rules For "Safe" Food Ingredients

On August 10, 2026, the U.S. Department of Health and Human Services ("HHS") announced the Food and Drug Administration's ("FDA") proposed new rule to change the way food substances are regulated. Food substances include food ingredients (such as salt and citric acid) and substances added indirectly to food via packaging components like adhesives and resins.
United StatesFood, Drugs, Healthcare, Life Sciences
Greenberg Glusker LLP
Greenberg Glusker LLP